This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University System of Maryland. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 961 
1 out of 2,029 
Years Active: 2026
Title: Vladimir Gerzanich: Innovator in Medical Treatments
Introduction
Vladimir Gerzanich is an accomplished inventor based in Elkridge, MD (US). He has contributed to the field of medical treatments, particularly focusing on methods for treating stroke and lung injury. Although he currently holds no granted patents, his work is significant in advancing medical science.
Latest Patent Applications
Vladimir Gerzanich has filed several notable patent applications. One of his latest applications is titled "Methods and Compositions for the Treatment of Stroke." This invention provides methods for treating reperfusion edema in patients who have suffered a stroke. The methods involve administering an effective amount of one or more inhibitors of sodium D-glucose cotransporter 2 (SGLT2). The invention also contemplates the administration of SGLT2 inhibitors in combination with recombinant tissue plasminogen activator (rt-PA). Exemplary SGLT2 inhibitors include canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, ipragliflozin, luseogliflozin, remogliflozin etabonate, sergliflozin etabonate, sotagliflozin, tofogliflozin, and combinations thereof. Another application is titled "Compositions and Methods for Treating Lung Injury." This invention provides methods of reducing lung injury in a subject in need thereof, comprising administering to the subject an effective amount of an agent that inhibits the activity of SUR1.
Conclusion
Vladimir Gerzanich's innovative work in medical treatments showcases his dedication to improving patient outcomes. His latest patent applications reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile